NASDAQ:AEZS

AEterna Zentaris Inc. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$5.72

+0 (+0%)

At Close: Oct 11, 2024

AEterna Zentaris Inc. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 AEZS shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

ABOUT AETERNA ZENTARIS INC.

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. T...

Read Full Profile Here